Belgium· BE-AMP-SAM233265-00
Clinoleic 20 %
A fettemulsionen product containing glycine soja siebold et zucc. - glycine max merr. (ph.eur. mixture) 20% + olea europaea l. 80%, oil - refined, registered in Belgium by Baxter. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fettemulsionen is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Fettemulsionen · ATC B05BA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Glycine soja Siebold et Zucc. - Glycine max Merr. (Ph.Eur. mixture) 20% + Olea europaea L. 80%, Oil - Refined
- Manufacturer
- Baxter
- Country
- Belgium (BE)
- ATC code
- B05BA02
- ATC class
- Fettemulsionen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
- be_apb1480466
- be_apb0760827
- be_apb1480474
- be_apb0760835
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05BA02
Fettemulsionen, as other registers publish it.
- NorwayClinoleicBaxter Medical AB
- FinlandClinoleicBaxter Oy
- DenmarkClinoleicBaxter A/S
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b67f9c52-a105-429e-902c-5ff6600e17a5 GET /v1/drugs/b67f9c52-a105-429e-902c-5ff6600e17a5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Emulsion for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Clinoleic 20 %",
"name_fr": "Clinoleic 20 %",
"name_nl": "Clinoleic 20 %",
"amp_code": "SAM233265-00",
"strengths": [
"200.0000",
"22.5000",
"0.3000"
],
"pack_count": 14,
"substances": [
"Glycine soja Siebold et Zucc. - Glycine max Merr. (Ph.Eur. mixture) 20% + Olea europaea L. 80%, Oil - Refined",
"Glycerol",
"Sodium Hydroxide",
"Sodium Oleate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fat Emulsions",
"authorisation_numbers": [
"BE233265",
"BE233274",
"BE233283",
"BE233292",
"BE233301"
]
}See everything about fettemulsionen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.